Case Report: Graves' disease in a toddler with maple syrup urine disease: therapeutic challenges and surgical resolution
Frontiers in Pediatrics · 11.05.2026 · 14
DOI: 10.3389/fped.2026.1803842 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 11.05.2026. Verfasst von Hebah Ghandora und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A two-and-a-half-year-old girl with a known diagnosis of Maple Syrup Urine Disease (MSUD) developed challenging Graves' disease while undergoing liver transplant workup for definitive MSUD management. Initial low-dose methimazole failed to control hyperthyroidism; gradual dose escalation resulted in better control; however, the patient developed hepatotoxicity. Dose reduction caused poorly controlled hyperthyroidism, further complicated by severe neutropenia, necessitating discontinuation. In addition, multiple MSUD catabolic crises further complicated the medical management. A total thyroidectomy was planned after metabolic stabilization and preoperative preparation. Perioperative management included Lugol's iodine, hydrocortisone, and propranolol, but hyperthyroidism paradoxically worsened within 24 h due to the iodine effect. Neutrophil count improved with high-dose hydrocortisone; careful reintroduction of low-dose methimazole, with close monitoring of the ANC, resulted in better control of hyperthyroidism. Another perioperative challenge included strict branched-chain amino acid restriction and high-dose insulin infusion to counter hydrocortisone metabolic risk, with careful special “sick days” management guided by a metabolic specialist to prevent neurological sequelae and metabolic crisis. Total thyroidectomy proceeded uneventfully after multidisciplinary optimization. Postoperative transient hypocalcemia was managed conservatively, and levothyroxine replacement was initiated. The patient successfully underwent liver transplantation several months later.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
- King Abdullah International Medical Research Center, National Guard Health Affairs, Jeddah, Saudi Arabia.
- Department of Pediatric Endocrinology, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.
- Department of Genetics and Precision Medicine, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.
- Department of ENT, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.
- Department of Clinical Nutrition, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, National Guard Health Affairs, Jeddah, Saudi Arabia.
Zitieren
APA
Ghandora, H., Alzahrani, M. K., Alsharif, R. L., Al Zahrani, H., Garni, M. A., & Jambi, H. (2026). Case Report: Graves' disease in a toddler with maple syrup urine disease: therapeutic challenges and surgical resolution. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1803842
Vancouver
Ghandora H, Alzahrani MK, Alsharif RL, Al Zahrani H, Garni MA, Jambi H. Case Report: Graves' disease in a toddler with maple syrup urine disease: therapeutic challenges and surgical resolution. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1803842
BibTeX
@article{Ghandora2026,
author = {Ghandora, Hebah and Alzahrani, Mays Khader and Alsharif, Rewa Lutfi and Al Zahrani, Haifa and Garni, Mohammed Al and Jambi, Hadeel},
title = {Case Report: Graves' disease in a toddler with maple syrup urine disease: therapeutic challenges and surgical resolution},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1803842}
}
EUVIMED